![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Clears Monitor for Coumadin Patients
FDA Clears Monitor for Coumadin Patients
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
The FDA granted 510(k) clearance for CoaguSense’s Coag-Sense PT2 meter, a second-generation monitoring device designed for patients taking the blood thinner Coumadin (warfarin).
The device can fit in a coat pocket and connects wirelessly to clinical networks or a patient’s at-home Bluetooth monitoring application to export test results. It can also connect through a wired Ethernet connection.
The meter assesses how long it takes for a patient’s blood to clot using prothrombin time (PT) and international normalized ratio (INR) tests.
Upcoming Events
-
21Oct